Europe Respiratory Care Devices Market Size
The Europe Respiratory Care Devices Market is projected to reach US$ 12.97 billion by 2033, up from US$ 6.8 billion in 2024, growing at a CAGR of 7.45% between 2025 and 2033. This substantial growth is driven by increasing prevalence of respiratory diseases, a growing aging population, heightened pollution levels, technological advancements in device design, rising demand for home healthcare, and increased health consciousness post-COVID-19. Additionally, supportive healthcare infrastructure and favorable government policies further stimulate market expansion.
Want pricing & detailed TOC? Enter your email:https://www.renub.com/request-sample-page.php?gturl=europe-respiratory-care-devices-market-p.php
Table of Contents
- Market Overview
- Growth Drivers
- Challenges
- Regional Analysis
- Germany
- France
- United Kingdom
- Other Key Countries
- Segmentation Analysis
- By Device Type
- By Product Type
- By Application
- By End-User
- Competitive Landscape
- Conclusion
Get Free Sample
Contact us for a comprehensive sample of the Europe Respiratory Care Devices Market report including detailed segmentation, forecasts, and company profiles.
Europe Respiratory Care Devices Market Size and Forecast 2025-2033
Market Overview of Respiratory Care Devices in Europe
Respiratory care devices are medical instruments designed to diagnose, monitor, and treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), obstructive sleep apnea (OSA), and acute respiratory infections. These devices include ventilators, nebulizers, oxygen concentrators, CPAP machines, inhalers, spirometers, and pulse oximeters. Historically used primarily in clinical settings, technological advancements have enabled increased adoption in homecare environments, driven by portability, automation, and improved patient comfort.
The European market is witnessing significant growth, fueled by a rise in respiratory illnesses caused by factors such as environmental pollution, smoking, and demographic shifts like population aging. Smart inhalers and AI-integrated monitoring devices further enhance patient adherence and enable remote healthcare management, reducing hospitalizations and healthcare costs.
Healthcare expenditure and robust regulatory support from governments across Europe are facilitating faster adoption of these advanced devices, thus accelerating market expansion.
Growth Drivers for the Europe Respiratory Care Devices Market
Rising Prevalence of Respiratory Diseases
Respiratory conditions such as asthma, COPD, and sleep apnea have seen an alarming rise in Europe. For example, asthma affects nearly 10% of children and 4-5% of adults in Germany alone. The increasing burden of such diseases, driven by pollution, smoking habits, urban lifestyle, and aging populations, fuels demand for respiratory care devices across diagnostic, monitoring, and therapeutic categories. This creates significant growth opportunities for device manufacturers focused on innovative and patient-centric solutions.
Technological Advancements
Europe’s respiratory care market benefits from cutting-edge innovations, including:
- Smart inhalers that track medication usage and improve compliance
- AI-enabled ventilators providing optimized respiratory support
- Portable oxygen concentrators enhancing mobility and quality of life
- Telemedicine and cloud-based remote patient monitoring systems
For instance, the collaboration between MAGNET GROUP and KoKo, LLC, leverages advanced lung function diagnostics to enhance spirometry testing, reflecting the trend towards precision medicine and remote healthcare delivery. Such innovations create new product lines and market expansion possibilities.
Aging Population
Europe has one of the oldest populations globally, with 21.6% of its 449.3 million inhabitants aged 65 and above (2024 data). Aging lungs are more susceptible to chronic respiratory diseases, necessitating increased use of devices like CPAP machines, nebulizers, and oxygen concentrators. The elderly’s preference for homecare further drives demand for user-friendly, portable devices that facilitate independence and reduce hospital visits, underscoring the strategic importance of this demographic.
Challenges in the Europe Respiratory Care Devices Market
High Cost of Devices
The advanced nature of respiratory care devices often results in high acquisition and maintenance costs, limiting accessibility for lower-income groups and straining public healthcare budgets. This cost barrier may delay device adoption and hinder equitable healthcare delivery, especially in countries with underfunded health systems.
Regulatory Hurdles
The introduction of the EU Medical Device Regulation (MDR) has increased requirements for clinical validation, labeling, and post-market surveillance, leading to longer product approval cycles and elevated compliance costs. Smaller manufacturers face difficulties navigating these regulations, potentially stifling innovation and slowing market entry of new technologies, ultimately impacting patient access to novel respiratory solutions.
Regional Analysis
Germany Respiratory Care Devices Market
Germany leads the European respiratory devices market due to a large elderly population and increasing respiratory conditions such as asthma and COPD. Innovative projects like the EUR 225,000 grant to develop wearable respiratory monitoring devices highlight the country’s focus on digital health. Major players including Philips Healthcare, ResMed, and Drägerwerk AG are active in advancing device technology and patient-centric solutions, promoting sustained growth.
France Respiratory Care Devices Market
France faces one of the highest asthma prevalence rates in Europe (~13.5%). The country is witnessing a steady increase in demand for respiratory care devices such as oxygen concentrators and nebulizers. Robust hospital infrastructure combined with a rising trend towards homecare services creates a favorable environment for market growth.
United Kingdom Respiratory Care Devices Market
The UK’s market is expanding with increasing respiratory disease incidence and technological innovation. Recent product launches, such as Honeywell’s NIOSH-certified respirators and Responsive Respiratory’s oxygen accessories, demonstrate the focus on healthcare worker safety and patient convenience. Homecare solutions are increasingly popular, supported by leading companies like Philips Healthcare and ResMed.
Other Key Countries
Countries such as Italy, Spain, Belgium, and the Netherlands are also experiencing growth due to similar demographic and epidemiological trends, enhanced healthcare infrastructure, and growing consumer awareness.
Segmentation Analysis
By Device Type
- Therapeutic Devices (e.g., CPAP machines, ventilators)
- Monitoring Devices (e.g., pulse oximeters, polysomnography devices)
- Diagnostic Devices (e.g., spirometers)
- Consumables & Accessories (e.g., masks, tubing)
By Product Type
- Respiratory Consumables
- Nebulizers
- Oxygen Concentrators
- Polysomnography Devices
- Pulse Oximeters
- Mechanical Ventilators
- Spirometers
- Others
By Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Obstructive Sleep Apnea
- Asthma
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Others
By End-User
- Hospitals
- Home Care
- Ambulatory Care
Competitive Landscape and Key Players
The Europe Respiratory Care Devices Market is highly competitive and consolidated with major global players leading innovation and market share:
- Medtronic Plc
- Koninklijke Philips
- General Electric Company
- Masimo Corporation
- ResMed Inc.
- Becton, Dickinson and Company
- Chart Industries Inc.
- Getinge AB
New Publish Blogs:
Top Transdermal Skin Patches Companies | Market Leaders 2025
Top Tilapia Companies Leading the Global Aquaculture Industry
Top Ice Cream Companies in the Global Market – 2025 Insights
These companies focus on research & development, partnerships, product launches, and geographic expansion to maintain competitive advantages. Recent collaborations and product innovations are shaping the market’s future trajectory.
Conclusion
The Europe Respiratory Care Devices Market is set for robust growth through 2033, propelled by rising respiratory disease prevalence, an aging population, and technological advancements. While high costs and regulatory complexities pose challenges, government support, and healthcare infrastructure improvements offer promising opportunities. Market players must continue innovating user-friendly, cost-effective, and technologically advanced respiratory solutions to capitalize on the expanding homecare trend and evolving patient needs across Europe.
About Renub Research
Renub Research is a leading market research and consulting company offering management consulting and in-depth industry analysis across various sectors. With a global perspective and a local understanding, Renub Research delivers insights that matter.
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: mailto:rajat@renub.com
